ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,367,126 | -22.4% | 497,474 | +3.0% | 0.08% | -17.7% |
Q2 2023 | $17,222,888 | +63.0% | 482,975 | +16.1% | 0.10% | +54.8% |
Q1 2023 | $10,566,000 | -39.7% | 416,005 | -8.6% | 0.06% | -42.1% |
Q4 2022 | $17,521,000 | +16.6% | 454,994 | +0.1% | 0.11% | +9.2% |
Q3 2022 | $15,028,000 | -15.6% | 454,717 | -10.0% | 0.10% | -12.5% |
Q2 2022 | $17,796,000 | -27.7% | 505,433 | -5.6% | 0.11% | -11.1% |
Q1 2022 | $24,631,000 | -28.8% | 535,586 | +4.2% | 0.13% | -17.1% |
Q4 2021 | $34,606,000 | +7.3% | 513,838 | -0.6% | 0.15% | +4.1% |
Q3 2021 | $32,263,000 | -32.7% | 516,789 | -10.7% | 0.15% | -29.1% |
Q2 2021 | $47,933,000 | +19.7% | 578,770 | -3.0% | 0.21% | +16.4% |
Q1 2021 | $40,035,000 | -22.4% | 596,918 | -11.2% | 0.18% | -39.2% |
Q4 2020 | $51,570,000 | +58.9% | 672,104 | -10.1% | 0.29% | +74.3% |
Q3 2020 | $32,461,000 | +7.6% | 747,623 | +5.6% | 0.17% | -2.9% |
Q2 2020 | $30,166,000 | +48.1% | 708,137 | +0.0% | 0.17% | +35.4% |
Q1 2020 | $20,365,000 | -54.4% | 707,867 | +0.5% | 0.13% | -40.9% |
Q4 2019 | $44,658,000 | – | 704,064 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |